SUVEN — Suven Life Sciences Cashflow Statement
0.000.00%
Last trade - 00:00- IN₹70.00bn
- IN₹64.99bn
- IN₹71.15m
Annual cashflow statement for Suven Life Sciences, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | 2026 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | PRESS |
| Standards: | IAS | IAS | IAS | IAS | — |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -1,220 | -1,183 | -1,061 | -1,607 | -2,763 |
| Depreciation | |||||
| Non-Cash Items | -46.6 | -10.9 | -283 | -93.4 | -120 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -44.5 | 104 | 131 | 107 | -191 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -1,275 | -1,031 | -1,155 | -1,541 | -3,018 |
| Capital Expenditures | -198 | -28.9 | — | -373 | -50.8 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -24.6 | -2,578 | 944 | 1,922 | -4,570 |
| Sale of Fixed Assets | |||||
| Change in Net Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -222 | -2,606 | 944 | 1,550 | -4,621 |
| Financing Cash Flow Items | -3.95 | -2.62 | -1.58 | -0.466 | — |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 1,457 | 3,955 | -10.5 | -7.56 | 7,572 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -40.7 | 317 | -221 | 0.931 | -67.5 |